Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
316.67
+6.00 (1.93%)
At close: May 12, 2025, 4:00 PM
320.05
+3.38 (1.07%)
After-hours: May 12, 2025, 6:39 PM EDT
Insulet Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Insulet stock have an average target of 303.82, with a low estimate of 223 and a high estimate of 355. The average target predicts a decrease of -4.06% from the current stock price of 316.67.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Insulet stock from 18 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 5 | 6 | 6 | 6 | 6 | 6 |
Buy | 8 | 7 | 7 | 8 | 7 | 8 |
Hold | 3 | 3 | 3 | 3 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 16 | 16 | 16 | 17 | 17 | 18 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy Maintains $312 → $324 | Buy | Maintains | $312 → $324 | +2.31% | May 9, 2025 |
Barclays | Barclays | Hold Maintains $234 → $266 | Hold | Maintains | $234 → $266 | -16.00% | Apr 30, 2025 |
Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 29, 2025 |
RBC Capital | RBC Capital | Buy Initiates $340 | Buy | Initiates | $340 | +7.37% | Mar 6, 2025 |
Citigroup | Citigroup | Strong Buy Maintains $310 → $355 | Strong Buy | Maintains | $310 → $355 | +12.10% | Feb 21, 2025 |
Financial Forecast
Revenue This Year
2.50B
from 2.07B
Increased by 20.53%
Revenue Next Year
2.93B
from 2.50B
Increased by 17.42%
EPS This Year
4.30
from 5.78
Decreased by -25.67%
EPS Next Year
5.29
from 4.30
Increased by 22.97%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.6B | 3.1B | 3.7B | ||
Avg | 2.5B | 2.9B | 3.4B | ||
Low | 2.4B | 2.7B | 3.1B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 26.1% | 25.2% | 26.0% | ||
Avg | 20.5% | 17.4% | 15.6% | ||
Low | 14.3% | 8.7% | 4.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 5.44 | 6.30 | 6.89 | ||
Avg | 4.30 | 5.29 | 6.28 | ||
Low | 3.77 | 3.95 | 4.24 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -6.0% | 46.6% | 30.3% | ||
Avg | -25.7% | 23.0% | 18.8% | ||
Low | -34.8% | -8.1% | -19.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.